Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance

In this articleAMGNLLYNOVO.B-DKThe injectable weight-loss medication Wegovy is available at New City Halstead Pharmacy on April 24, 2024 in Chicago, Illinois.Scott Olson | Getty ImagesNovo Nordisk and Eli Lilly have long dominated the rapidly growing weight loss drug market, but their duopoly is closer than ever to facing a threat from a new rival. Amgen is among the leaders of a pack of drugmakers racing to join the market with their own weight loss treatments. As the company pushes forward with the trials ...